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Abstract-The effect of hemicholinium (HC-3) on choline distribution was studied in 
aivo in the subcellular fractions of the canine caudate nucleus. Both HC-3 and choline 
were given intraventricularly to locally anesthetized, decamethonium-paralyzed dogs 
maintained on artificial ventilation. At various time intervals after intraventricular 
injection of methyl-W-choline alone and in various HC-3/methyl-W-choline ratios, 
the animals were sacrificed by air embolus and the caudate was removed and subjected 
to subcellular fractionation. It was found that methyl-W-choline accumulated primarily 
in the microsomal (Mic) and the nerve ending, mitochondria, lysosome (NEML) 
fractions. There was greater accumulation at 4 hr than at 1 hr. The combined injection 
of HC-3 and methyl-W-choline in ratios of 10, 100, 500 and 2500 progressively 
increased the uptake of choline by the subcellular elements; an extract of the water- 
soluble components of fraction NEML showed that HC-3 reduced the conversion of 
choline to acetylcholine. On the other hand, HC-3 increased the labeling of phosphoryl- 
choline and, particularly, of cytidine diphosphocholine. The levels of free choline in the 
caudate were not affected by:HC-3. 
ALTHOUGH the role of acetylcholine as a neurotransmitter in the central nervous 
system is now widely recognized,‘-3 not much is known about the metabolic origin of 
its choline moiety. Only recently has this topic received attention,d-12 and it is now 
clear that the synthesis of most of the choline does not occur in the brain, but rather, 
that choline is supplied to the brain from extracerebral sources such as the liver. 
Most experiments in which the uptake of choline by the central nervous system was 
examined have used tissue slices. For example, Schuberth et al.5 examined the uptake 
of choline by mouse cortical slices; they concluded that, although choline entered the 
slice by an active transport mechanism, it was not “significantly metabolized by this 
tissue”. More recently Chakrin and Shideman’ studied the conversion of methyl-sH- 
labeled choline to acetylcholine by cat cerebral cortex, while Browning and SchulmaG 
studied the use, for acetylcholine synthesis, of other possible precursors such as 
ethanolamine, methionine and serine as well as acetate or glucose. Choline uptake by 
isolated guinea pig cortex nerve endings has also been described.* 
* A preliminary report was presented at the Federation Meetings in Atlantic City, April, 1969; 
Fedtt Proc. 28, 292 (1969). 
t Supported in part by U.S. Public Health Service Grants MH-11846 (E.F.D.) and NB-06294 
(O.Z.S.). 
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Hemicholinium-3 (a,a’-dimethylethanolamino-3,4’-bis acetophenone; HC-3),14 an 
agent which interferes with the synthesis of acetylcholine in the nervous system has 
been widely used in studies of the relationship between the tissue uptake of choline 
and its conversion to acetylcholine (see, for example, references 11, 15, 16). It has 
been shown that small doses (lo-100 pg total) of HC-3, given intraventricularly to 
dogs, cause a marked lowering of acetylcholine levels,17 particularly in the caudate 
nucleus and the hippocampus. More recently, Sellinger et ~1.18 have reported that, 
after its intraventricular administration to dogs, HC-3 binds with a high affinity to 
synaptic membranes of the caudate nucleus and hippocampus. It has also been shown]” 
that the reduction of acetylcholine levels in rat brain elicited by intraventricular HC-3 
can be prevented if choline is administered simultaneously. 
In order to relate our previous finding+* on the intracellular distribution of HC-3 
in the caudate nucleus to the accepted ability of the drug to interfere with the tissue 
uptake of choline, we have examined the latter process as it occurs in vice in the 
caudate nucleus of the dog. The caudate nucleus was chosen because of its very high 
content of acetylcholine. The present paper reports on the uptake of choline by the 
subcellular components of this tissue, as well as on the initial steps in the metabolic 
disposition of the choline molecule. The influence on these processes, viz. uptake and 
metabolic disposition, of HC-3 is also documented. The data indicate that choline 
uptake by the fractions containing the nerve endings, mitochondria and lysosomes 
(NEML) and the membranes of the endoplasmic reticulum (Mic) increased as a 
function of injection time (up to 4 hr). HC-3 decreased the conversion of labeled 
choline into acetylcholine and, surprisingly, increased the labeling of phosphoryl- 
choline and of cytidine diphosphocholine. 
MATERIALS AND METHODS 
Chenzicals. Hemicholinium bromide was obtained from the Aldrich Chemical Co. 
Its purity was checked by chromatography on Whatman no. 1 paper in a solvent 
system of n-butanol-glacial acetic acid-water (4:1:2) using Dragendorff’s reagentZO fol 
its visualization. An Rf value of 0.49 was obtained. Me-*“C-choline chloride was from 
New England Nuclear (7.6 me/m-mole) or Amersham-Searle (54 me/m-mole). Phos- 
phorylcholine-l,2-14C (9.4 me/m-mole) and cytidine diphosphocholine-1 ,-2-14C (0.3 
me/m-mole) were from Tracerlab. Me-14C-acetylcholine chloride (10.4 me/m-mole) 
was from Nuclear Chicago. The purity of Me-14C-choline and its derivatives was 
determined by thin-layer chromatography as described below. Other chemicals used 
included acetylcholine (Aldrich), cytidine diphosphocholine (Sigma), choline chloride 
(Calbiochem) and phosphorylcholine (Ca salt; Mann). 
Animals. Beagle-like mongrel dogs of either sex (S-13 kg) were used. They were 
anesthetized with NsO-02 (80:20), paralyzed with decamethonium, intubated and 
artificially respired as described previously. 17,~ Both HC-3 and choline were injected 
into the left lateral ventricle. Sacrifice by intravenous air embolus and removal of the 
whole brain were made at 1 and 4 hr after the intraventricular injection of 2, 10 or 
100 pg Me-14C-choline. The caudate nucleus was dissected free and placed into a 
preweighed beaker containing ice-cold 0.25 M sucrose and physostigmine salicylate, 
5 x 10-J M. 
Preparation of subcellular fractions. The caudate nucleus was homogenized in the 
sucrose-physostigmine solution with seven excursions of the Teflon-stainless pestle in 
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a glass tube (A. H. Thomas Co., Philadelphia, Pa.; item no. 4288). The 5% (w/v) 
homogenate was centrifuged at 800 g for 10 min, yielding a pellet and a supernatant. 
The pellet was resuspended in the sucrose-physostigmine solution, homogenized and 
resedimented at 800 g for 8 min. This was repeated once more, yielding the nuclear 
fraction (N). The pooled supernatants were combined and centrifuged at 10,000 g for 
15 min. The pellet was washed, homogenized and centrifuged at 10,000 g for 12 min to 
yield the fraction containing nerve endings, mitochondria and lysosomes (fraction 
NEML). The supernatants from this fraction were combined and centrifuged at 
100,~ g for 60 min, yielding the mi~rosomal fraction (Mic) and the soluble super- 
natant (S). All centrifugations were performed in a Spinco preparative centrifuge at 4”. 
Choline assay. Free choline was determined by the method of Long et aZ.,2l after 
separation from phosphorylcholine and cytidine diphosphocholine by the method of 
AnseIl and Spanner.9 Tissue samples were removed and placed in a freezer (-20”) 
before assay. 
C~zroff?u~og$aph~c procedures. Sucrose was removed from the water-soluble tissue 
extracts2 by passage through a small (I.0 x 8 cm) column of Rexyn-300 (H-OH; 
Fisher). Elution of the radioactive choline and metabolites was accomplished by 
washing the column with 80 ml of 0.1 M NH4 acetate. Separation of choline, phos- 
phorylcholine and cytidine diphosphocholine was by thin-layer chromatography 
(TLC) on cellulose powder MN-3~ (Macherey, Magell Co.). The chromatograms 
were run at room temperature for a length of 12-15 cm in a solvent consisting of 
n-butanol-ethanol-acetic acid-water (8:2:1:3). For optimal separation of phosphoryl- 
choline and cytidine diphosphocholine, the chromatogram was run twice with the 
same solvent. The separation achieved is illustrated in Fig. 2. @-standards were used to 
identify the location of each 14C-compound on the TLC plate. The dry plates were 
exposed to iodine vapors for visualization of the spots, which were marked, scraped 
off and transferred to scintillation vials. The iodine color was bleached by adding 0-l 
ml of 2 % NaHSOs to each vial. Water (0.5 ml) was also added to facilitate the elution 
of the compounds from the cellulose. The scintillation mixture (see below) contained 
IO “/* (v/v) of Biosolv-3 (Beckman). 
Autoradiograms were made on Kodak X-ray film (Type AA-54) and were developed 
in Supermix (General Electric). 
Radioactivity procedures. The radioactivity was measured in a Beckman liquid 
scintillation spectrometer (LS-200). The internal standard method was used to correct 
for quenching. Aliquots (0.3 ml) of the subcellular fractions were solubilized in NCS 
(Nuclear Chicago) and 15 ml of a scintillation mixture consisting of toluene (1 liter), 
2,5-diphenyloxazole (5 g) and l,4-bis-2-(4-methyl-5-phenyloxazolyl)benzene (O-1 g) 
was then added. 
RESULTS 
Lack of efjrect of intraventricular He-3 on free choline levels 
Free choline in the canine caudate nucleus was determined in eight animals. The 
mean choline level &SD. was I.36 -& 0.28 pmoles/g of tissue. One hr or 4 hr after 
HC-3 (50 mg, intraveI~tricularly), the mean of the choline levels in six animals was 
closely similar, 1.52 -f 0.10 pmoles/g. There was therefore no significant difference 
(P > 0.5) between the levels of choline in the control and the HC-3-treated animals, in 
contrast to the marked decrease in acetylcholine levels which this drug is known to 
elicit. 
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Eflect of time and dose on the intracellular distribution of choline radioactivity 
After the injection of 2, 10 or 100 pg Me-W-choline, the absolute levels of radio- 
activity in the subcellular fractions at 4 hr were much higher than those present at 1 hr. 
TABLE 1. DISTRIBUTION OF RADIOACTIVITY IN SUBCELLULAR FRACTIONS OF THE CAUDATE 
NUCLEUS AFTER THE ADMINISTRATION OF Me-14C-CHOL1NE* 








(hr) NEML Mic -~ s 
2 3 : 17.2 & 0.8 11.9 * 1.8 68.0 :I 2.0 
25.8 & 1.4 22.2 i 3.8 44.3 * 3.0 
10 3 : 13.9 :k 0.4 13.5 i 0.1 69.6 ri_ 1.1 
27.7 -C 1.3 18.8 + 1.6 42.3 -I- 2.2 
100 2 : 14.1 i-is.2 13.87i7.0 65.0-70.2 
26.8; 28.0 19.5; 22.9 46.2; 49.4 
70 











* Intraventricular = i. vent.; number of animals = n; NEML = nerve endings, mitochondria, 
lysosomes; Mic = membranes of the endoplasmic reticulum -I- ribosomes; S = soluble fraction, 
isolated according to de Robertis et ~1.~3 




PIG. 1. Effect of HC-3 onmethyl-W-choline radioactivity distribution in the subcellular fractious 01 
the dog caudate nucleus. The y-axis represents the per cent of the total dpm/g & S.D. in the fraction 
and the x-axis the ratio: HC-3/Me-W-choline. The dose of choline was 10, 10, 10, 10 and 2 pg, while 
that of HC-3 was 0, 100, 1000,5000 and 5000. Three animals were used for each dose ratio, except for 








FIG. 2. Autoradiogram of separated mixture of choline. acetylcholine, phosphorylcholine and 
cytidine diphosphocholine. ACh, acefylcholine: Ch, choline; PC. phosphorylcholine; CDP-Ch. 
cytidine diphosphocholine. 
B.P.-facifzg pap? I756 
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As indicated in Table 1, the percentage uptake into the NEML fraction was somewhat 
greater than that into the Mic fraction at 4 hr, while the percentage of radioactivity in 
the soluble portion (fraction S) did not appreciably change from 1 to 4 hr with the 
different doses of choline. This dose independence of the distribution of the radio- 
activity was also shown by the particulate fractions. 
Effect of increasing ratios of hemicholinium to choline on the intracellular distribution of 
Me- WAholine 
As shown in the upper part of Fig. 1, increasing the ratio of HC-3/MeJ4C-choline 
from 0 to 2500 had no effect on the distribution of radioactivity in the four major 
subcellular fractions 1 hr after their simultaneous intraventricular injection. However, 
4 hr after HC-3 plus choline, the percentage of the total radioactivity in fractions 
NEML and Mic had increased, the increase being greatest in the latter fraction (from 
18 % with no HC-3 to 32 % at the highest HC-3 to choline ratio). There was a corres- 
ponding decrease of radioactivity in the soluble fraction S, suggesting a facilitating 
effect of HC-3 on the uptake of choline by the particulate fractions, NEML and Mic. 
However, there was no change in the percentage of radioactivity in the nuclear (N) 
fraction as a function of the HC-3 to choline ratio, although, in absolute values, the 
incorporation of radioactivity into this fraction was also somewhat higher at 4 hr than 
at 1 hr postinjection. 
Effect of HC-3 pretreatment on the intracellular distribution of MeJ4C-choline 
When choline was given alone, the highest percentage of radioactivity was found in 
the soluble fraction (S) both at 1 and 4 hr (Table 2). However, this fraction showed a 
decrease in radioactivity at 4 hr compared to 1 hr which was counterbalanced by a 
corresponding increase in the particulate fractions (N, NEML and Mic; Table 2). The 
simultaneous administration of HC-3 (5 mg) and Me-14C-choline (2 pg) resulted in a 
moderate increase in the uptake of choline by the Mic fraction at 1 hr as compared to 
when choline was given alone. However, at 4 hr, there was a much greater decrease in 
the water-soluble radioactivity in fraction S and a correspondingly high increase of 
TABLEZEFFECTOFHC-3 PRETREATMENTONTHEDISTRIBUTIONOF Me-14C-CHoLINE 


















Per cent of total recovered radioactivity? 
Time of (dpm/g) 
sacrifice 
(hr) N NEML Mic s 
: 7.9 2 8 + & 0.96 1 72 25.8 17.2 + f 0.75 1 4 22.0 1 .  -I i 3.8 1 44.3 68 0 :t + 2.0 3
: 5.4 9 8 + _I: 2.4 3 2 17.3 34 1 * & 1.85 5 7 17.0 30 + rf_ 2.3 3.0 60.3 27 1 + t 4.5 9
: 5.7; 8.9 16.3; 18.3 11.0; 11.8 67.0; 61.0 
10.2; 10.4 32.0; 25.0 31.8; 30.0 26.0; 34.6 
: 7.6 22.4 15.3 54.7 
15.1 22.5 22.6 39.8 
* Methyl-14C-choline was injected intraventricularly along with HC ?, as noted. The specific 
activity of the labeled choline was 7.6 me/m mole. Total volume of each mjection was @2 ml. The 
injected doses: HC-3, 5 mg; Me-14C-choline, 2 pg. See Table 1 for abbreviations. N=nuclei 
t For n = 3, 4 or 5, means I SD. are given; for n = 2, individual values are given. 
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the radioactivity in the particulate fractions, especially fraction NEML. When com- 
pared with the control animals who received choline alone, a 2-hr pretreatment with 
HC-3 did not seem to affect the distribution of choline radioactivity 1 hr after choline 
injection. Four hr after choline injection, there was an increase in the Mic fraction 
(30.4%) as compared to 4 hr after choline alone (22.0%). A 4-hr pretreatment with 
He-3 had no effect on the distribution of radioactivity when tested 4 hr after choline. 
However, 1 hr after choline, an increase in the uptake of radioactivity in both 
particulate fractions could be discerned; it was greater in fraction NEM L (22.4 “,L vs. 
17.3 %) than in fraction Mic (15.3 vs. 12.0%). 
Effkct qf NC-3 on the distribution of water-soluble choline tnetabolitcs 
The water-soluble metabolites of choline, namely cytidine di~l~ospho~holil~~ 
(CDP-Ch), phosphorylcholine (PC) and acetylcholine (ACh) were separated from 
choline by TLC. Figure 2 shows a model autoradiogram of the separated labeled 
standards. For identification of the radioactive tissue choline metabolites, they were 
co-chromatographed with authentic Y-standards which were visualized by suitable 
spray reagents for choline derivatives, 20 phosphorus or by ultraviolet fluorescence. 
The effect of increasing the ratio HC-3/Me-t”C-choline on the distribution of the 
water-soluble choline tnetabolites in fractions NEML and S is shown in Fig. 3. A 
ratio of 500 reduced the ACh in the NEML fraction as expected. No labeled ACh 
/ 
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0 IO 100 !500 
HC-3/Me.C’4-Chcllne 
Rot10 
FIG. 3. Effect of HC-3 on the formation of water-soluble metabolites of cl~oline. The animals were 
sacrificed 1 hr after the simultaneous intraventricular injection of HC-3 and choline. Details are the 
same as in Fig. 1, except that the HC-3/MeJ4C-choline ratio of 2500 was omitted. 
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was found in fraction S under the conditions of these experiments, in spite of the 
presence of 5 x 10-J M physostigmine to prevent ACh hydrolysis. Free choline 
decreased in fraction NEML with increasing HC-3/choline ratios, while phosphoryl- 
choline tended to increase in the NEML and decrease in the S fraction. Particularly 
noteworthy, however, was the increase of CDP-Ch in fraction NEML at the highest 
HC-3/Me-W-choline ratio. 
DISCUSSION 
This investigation shows that the dog caudate nucleus accumulates radioactivity 
injected as Me-14C-choline. Since our data indicate that the free choline content of 
the caudate is 1.35 prnoles/g of tissue, a concentration of less than 0.1 pmole choline 
injected into the ventricle would not be expected to reach the caudate without an active 
transport mechanism. Yet, direct evidence that choline actively concentrates in the 
caudate from the cerebrospinal fluid is lacking and Ansell and Spanner9 have sug- 
gested that, instead, the liver is the major source of cerebral choline. 
The accumulation of radioactivity was significant in subcellular fractions, NEML 
and Mic. In mouse brain slices, Schuberth et al.5 demonstrated that choline is con- 
centrated in nerve endings and mitochondria, while Marchbankss suggested that 
cerebral mitochondria take up choline with approximately the same kinetics as do 
nerve endings. 
Sellinger et al.18 studied the distribution ofr%-HC-3 among the subcellular fractions 
of the canine caudate nucleus. They found that the NEML fraction had a greater 
ability to concentrate HC-3 than the other fractions studied. At 4 hr after the 
administration of i4C-HC-3, 61 per cent of the tissue radioactivity was found in this 
fraction. In the present experiments, choline radioactivity was also appreciable in this 
fraction, but amounted to only about 30 per cent of the total tissue radioactivity. This 
suggests a difference in the rate of intracellular flux for the two compounds, choline 
and HC-3. 
To our knowledge there are no previous data on the uptake of choline by brain 
microsomes. This fraction showed a definite choline accumulation both alone and 
after HC-3 pretreatment (Table 2). Since this uptake may be related to the fact that 
both microsomes and mitochondria can synthesize phospholipids,a4 it is likely that 
some of the radioactive choline was made into phospholipids within the membrane- 
laden NEML and Mic fractions. Evidence for this contention as well as the demon- 
stration of an activating effect of HC-3 on this overall process is presented elsewhere.‘;’ 
The data obtained shed no light on the effect of HC-3 on the mechanism of the 
tissue uptake of choline, but only on its intracellular metabolic disposition. It is 
interesting that, heretofore, most investigators have studied only the effect of HC-3 
on the conversion of choline to acetylcholine” and only a few on its conversion to 
phosphorylcholine.le* 2s Only Hebb et aI., to our knowledge, mentioned the presence 
of a great deal of the injected choline radioactivity in the alcoholic extracts of the 
caudate nucleus, yet they failed to explore its presumable lipid nature. The present 
study, in which such an exploration was made, has revealed that HC-3 accelerates the 
metabolic utilization in Gvo of cerebral choline along the quantitatively dominant 
pathway of lipid formation via cytidine diphosphocholine.9 
* M. V. Gomez, E. F. Domino and 0. 2. Sellingcr, submitted for publication. 
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